Soluble urokinase plasminogen activator receptor: An indicator of pneumonia severity in children

Advances in Experimental Medicine and Biology

Volumn 835, Issue , 2014, Pages 1-7

  Wrotek, A ^a,b   Jackowska, T ^a,b   Pawlik, K ^a,b  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b BIELANSKI HOSPITAL   (Poland)

Author keywords

Acute illness; Dyspnea; Outcome; Pneumonia severity marker; Respiratory tract infection

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; UROKINASE; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; CALCITONIN; MONOVALENT CATION; PROTEIN PRECURSOR; SODIUM; UROKINASE RECEPTOR;

ARTICLE; BLOOD OXYGEN TENSION; BREATHING RATE; CHILD; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FEVER; HEART RATE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEWBORN; OXYGEN SATURATION; PNEUMONIA; ADOLESCENT; BLOOD; CASE CONTROL STUDY; COMMUNITY ACQUIRED INFECTION; GENE EXPRESSION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; LENGTH OF STAY; METABOLISM; PATHOPHYSIOLOGY; PNEUMONIA, BACTERIAL; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; SOLUBILITY;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CASE-CONTROL STUDIES; CATIONS, MONOVALENT; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; FEVER; GENE EXPRESSION; HEART RATE; HUMANS; IMMUNITY, INNATE; INFANT; INFANT, NEWBORN; LENGTH OF STAY; MALE; PNEUMONIA, BACTERIAL; PROTEIN PRECURSORS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SEVERITY OF ILLNESS INDEX; SODIUM; SOLUBILITY;

EID: 84914169282     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/5584_2014_40     Document Type: Article

References (22)

1. Backes Y, van der Sluijs KF, Mackie DP, Tacke F, Koch A, Tenhunen JJ, Schultz MJ (2012) Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: asystematic review. Intensive Care Med 38:1418-1428
2. De Witte H, Sweep F, Brunner N, Heuvel J, Beex L, Grebenschikov N, Benraad T (1998) Complexes between urokinase-type plasminogen activator and its receptor in blood as determined by enzymelinked immunosorbent assay. Int J Cancer 77:236-242
3. Eugen-Olsen J, Gustafson P, Sidenius N, Fischer TK, Parner J, Aaby P, Gomes VF, Lisse I (2002) The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau. Int J Tuberc Lung Dis 6:686-692
4. Garcia-Monco JC, Coleman JL, Benach JL (2002) Soluble urokinase receptor (uPAR, CD87) is present in serum and cerebrospinal fluid in patients with neurologic diseases. J Neuroimmunol 129:216-223
5. Gyetko MR, Sud S, Kendall T, Fuller JA, Newstead MW, Standiford TJ (2000) Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J Immunol 165:1513-1519
6. Gyetko MR, Aizenberg D, Mayo-Bond L (2004) Urokinase-deficient and urokinase receptor-deficient mice have impaired neutrophil antimicrobial activation in vitro. J Leukoc Biol 76:648-656
7. Huttunen R, Syrjanen J, Vuento R, Hurme M, Huhtala H, Laine J, Pessi T, Aittoniemi J (2011) Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. J Intern Med 270:32-40
8. Kofoed K, Eugen-Olsen J, Petersen J, Larsen K, Andersen O (2008) Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor. Eur J Clin Microbiol Infect Dis 27:375-383
9. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, Mathers C, Black RE, Child Health Epidemiology Reference Group of WHO, UNICEF (2012) Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379:2151-2161
10. Madhi SA, De Wals P, Grijalva CG, Grimwood K, Grossman R, Ishiwada N, Lee PI, Nascimento-Carvalho C, Nohynek H, O’Brien KL, Vergison A, Wolter J (2013) The burden of childhood pneumonia in the developed world: a review of the literature. Pediatr Infect Dis J 32:e119-e127
11. Ostrowski SR, Katzenstein TL, Piironen T, Gerstoft J, Pedersen BK, Ullum H (2004) Soluble urokinase receptor levels in plasma during 5 years of highly active antiretroviral therapy in HIV-1-infected patients. J Acquir Immune Defic Syndr 35:337-342
12. Ostrowski SR, Piironen T, Hoyer-Hansen G, Gerstoft J, Pedersen BK, Akanmori BD, Kurtzhals JA (2005a) High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients. J Acquir Immune Defic Syndr 39:23-31
13. Ostrowski SR, Ullum H, Goka BQ, Høyer-Hansen G, Obeng-Adjei G, Pedersen BK, Akanmori BD, Kurtzhals JA (2005b) Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome. J Infect Dis 191:1331-1341
14. Plesner T, Behrendt N, Ploug M (1997) Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Stem Cells 15:398-408
15. Sidenius N, Sier CF, Blasi F (2000a) Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo. FEBS Lett 475:52-56
16. Sidenius N, Sier CF, Ullum H, Pedersen BK, Lepri AC, Blasi F, Eugen-Olsen J (2000b) Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood 96:4091-4095
17. Sier CF, Stephens R, Bizik J, Mariani A, Bassan M, Pedersen N, Frigerio L, Ferrari A, Danø K, Brunner N, Blasi F (1998) The level of urokinasetype plasminogen activator receptor is increased in serum of ovarian cancer patients. Cancer Res 58:1843-1849
18. Stephens RW, Nielsen HJ, Christensen IJ, Thorlacius-Ussing O, Sørensen S, Danø K, Brunner N (1999) Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J Natl Cancer Inst 91:869-874
19. Toldi G, Beko˝ G, Kádár G, Mácsai E, Kovács L, Vásárhelyi B, Balog A (2013) Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission. Clin Chem Lab Med 51:327-332
20. Wiersinga WJ, Kaqer LM, Hovius JW, ven der Windt GJ, de Vos AF, Meijers JC, Roelofs JJ, Dondorp A, Levi M, Day NP, Peacock SJ, van der Poll T (2010) Urokinase receptor is necessary for bacterial defense against pneumonia-derived septic melioidosis by facilitating phagocytosis. J Immunol 184:3079-3086
21. Wittenhagen P, Andersen JB, Hansen A, Lindholm L, Ronne F, Theil J, Tvede M, Eugen-Olsen J (2011) Plasma soluble urokinase plasminogen activator receptor in children with urinary tract infection. Biomark Insights 6:79-82
22. Wrotek A, Pawlik K, Jackowska T (2013) Soluble receptor for urokinase plasminogen activator in community-acquired pneumonia in children. Adv Exp Med Biol 788:329-334